To Compare the Efficacy and Safety of INS068 and Insulin Glargine in Subjects With Type 2 Diabetes Mellitus Not Adequately Controlled With Oral Antidiabetic Drugs

NCT05699408 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

513

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes

Interventions

DRUG: INS068 injection
DRUG: Insulin Glargine

Sponsor

Jiangsu HengRui Medicine Co., Ltd.